Iraqi Journal of Embryos and Infertility Researches
Login
IJEIR
  • Home
  • Articles & Issues
    • Latest Issue
    • All Issues
  • Authors
    • Submit Manuscript
    • Guide for Authors
    • Authorship
    • Article Processing Charges (APC)
  • Reviewers
    • Guide for Reviewers
    • Become a Reviewer
  • Policies
    • Publication Ethics
    • Plagiarism
    • Allegations of Misconduct
    • Appeals and Complaints
    • Corrections and Withdrawals
    • Open Access
    • Copyright Policy
    • Archiving Policy
    • Privacy Policy
  • About
    • About Journal
    • Aims and Scope
    • Editorial Team
    • Journal Insights
    • Peer Review Process
    • Announcements
    • Contact

Search Results for mpa

Article
Comparison between Progesterone-Primed Protocol and GnRH Antagonist Protocol on Oocyte Yield and Fertilization Rate in PCOS Females

Zahraa Ali, Muayad Sraibet Abood, Mufeda Ali Jwad

Pages: 40-52

PDF Full Text
Abstract

Polycystic ovary syndrome (PCOS) is a common cause of anovulatory infertility and is associated with an increased risk of premature luteinizing hormone (LH) surges during controlled ovarian stimulation. Progestin-primed ovarian stimulation (PPOS) using Medroxyprogesterone Acetate (MPA) has emerged as a convenient alternative to conventional gonadotropin-releasing hormone (GnRH) antagonist protocols. This study aimed to compare the effects of MPA-based PPOS and GnRH antagonist protocols on oocyte yield, maturation, fertilization, and embryo quality in women with PCOS undergoing ICSI . This prospective, randomized, open-label controlled clinical trial included 108 women with PCOS undergoing ICSI at the High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq, between 2023 and 2024. Participants were allocated to an MPA-based PPOS group (n=49) or a flexible GnRH antagonist group (n=59). Oocyte yield, metaphase II (MII) oocytes, fertilization rate, embryo quality, ovarian sensitivity index (OSI), gonadotropin consumption, stimulation duration, and LH profiles were evaluated.No significant differences were observed in baseline characteristics or hormonal profiles between groups. The MPA group showed a numerically higher number of retrieved oocytes (20.65 ± 7.50 vs. 13.39 ± 4.41; p=0.083) and MII oocytes (15.10 ± 5.20 vs. 11.24 ± 4.12; p=0.09), although these differences were not statistically significant. Fertilization rates were comparable between groups (72.4 ± 10.6% vs. 71.2 ± 11.3%; p=0.68), as were embryo quality, OSI, gonadotropin consumption, and stimulation duration. Both protocols effectively suppressed premature LH surges without premature ovulation or cycle cancellation. MPA-based PPOS appears to be an effective and practical alternative to GnRH antagonist protocols for PCOS patients undergoing ICSI, providing comparable fertilization and embryological outcomes with effective LH suppression. Its oral administration and potential cost advantages may be particularly valuable in resource- limited ART settings.

1 - 1 of 1 items

Search Parameters

Journal Logo
Iraqi Journal of Embryos and Infertility Researches (IJEIR)

High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University

  • Copyright Policy
  • Terms & Conditions
  • Privacy Policy
  • Accessibility
  • Cookie Settings
Licensing & Open Access

CC BY 4.0 Logo Licensed under CC-BY-4.0

This journal provides immediate open access to its content.

Editorial Manager Logo Elsevier Logo

Peer-review powered by Elsevier’s Editorial Manager®

Copyright © 2026 Al-Nahrain University, its licensors, and contributors. All rights reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.